Insider Trading & Ownership - Contineum Therapeutics Inc. (CTNM)

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Contineum Therapeutics Inc.
Goto Prev, 0, 1

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
Company Symnbol Insider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing

Ownership
2024-04-04
5:56 pm
N/A
2034-03-26
Contineum Therapeutics Inc. CTNM Brady Todd R.
Director
0 $0 29,479
(Direct)
View

Ownership
2024-04-04
5:54 pm
N/A
2030-02-24
Contineum Therapeutics Inc. CTNM Huhn Stephen L.
CMO & Sr VP, Clinical Dev.
0 $0 236,725
(Direct)
View

Ownership
2024-04-04
5:52 pm
N/A
2030-10-05
Contineum Therapeutics Inc. CTNM Slover Peter T
Chief Financial Officer
0 $0 237,618
(Direct)
View

Ownership
2024-04-04
5:51 pm
N/A
N/A
Contineum Therapeutics Inc. CTNM Lorrain Daniel S.
Chief Scientific Officer
0 $0 670,865
(Direct)
View

Ownership
2024-04-04
5:49 pm
N/A
N/A
Contineum Therapeutics Inc. CTNM Stengone Carmine N.
CEO and President
0 $0 981,519
(Direct)
View
Goto Prev, 0, 1